← All patents

US20220016069A1

Glutaminase inhibitor therapy

University of Texas System

Abstract

Disclosed herein are methods of treating a tumor or cancer in a subject whose tumor or cancer cells express low levels of asparagine synthetase (ASNS), and compounds and compositions useful in such treatment. Also disclosed herein are methods of evaluating whether to administer a compound that …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Timothy Heffernan
Priority date
October 18, 2017
Filing date
May 21, 2021
Publication date
January 20, 2022
Language
en
Metadata fetched
August 29, 2026 00:29